1. CTIM-32. FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME. (14th November 2022) Authors: Johnson, Theodore; Pacholczyk, Rafal; Aguilera, Dolly; Al-Basheer, Ahmad; Bajaj, Manish; Bandopadhayay, Pratiti; Berrong, Zuzana; Bouffet, Eric; Castellino, Robert; Dorris, Kathleen; Eaton, Bree; Esiashvili, Natia; Foreman, Nicholas; Fridlyand, Diana; Giller, Cole; Heger, Ian; Kadom, Nadja; Kenne... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗